Published in:
01-07-2004 | Case Report
Drug-induced lupus erythematosus secondary to nafcillin: the first reported case
Published in: Rheumatology International | Issue 4/2004
Login to get accessAbstract
With an estimated incidence of 15–30,000 cases per year in the United States, drug-induced lupus erythematosus (DIL) is an uncommon iatrogenic condition. The number of implicated medications increases each year. We report the first case of DIL secondary to nafcillin administration in a patient with a prosthetic aortic valve and methicillin-sensitive Staphylococcus aureus who developed a facial rash and lower back pain.